How Does Ketamine Work for Depression? A Plain-Language Explanation

If you've been prescribed an antidepressant, you've probably been told "it takes four to six weeks to kick in." That's true for SSRIs (Prozac, Zoloft, Lexapro) and SNRIs (Effexor, Cymbalta). It is not true for ketamine. Most patients feel the first shift within hours.

The reason comes down to a different system in the brain. SSRIs work on serotonin. Ketamine works on glutamate. That one-sentence difference is the whole story, and it's worth understanding in more detail because it explains almost everything about how the treatment actually feels.

The serotonin system vs. the glutamate system

Serotonin is one neurotransmitter among many in the brain. SSRIs increase its availability at synapses, and over weeks of that increased availability, the brain gradually adjusts. Downstream effects include improved mood, reduced anxiety, often a flattening of emotional range. The slow timeline is because the mood change isn't the direct effect of the medication — it's the end result of weeks of the brain adapting to a new serotonin environment.

Glutamate is different. It's the most abundant excitatory neurotransmitter in the brain, the main signal that neurons use to talk to each other. Roughly 80% of synapses in the cortex are glutamate synapses. When depression has taken hold for a long time, there's evidence that the cortical glutamate signaling gets worse — fewer functional connections, pruned dendritic spines, a brain that's structurally quieter than it should be.

Ketamine directly modulates the glutamate system, specifically the NMDA receptor. It interrupts the ongoing signaling for a few hours, which triggers a fast cascade of downstream effects: a surge of prefrontal glutamate release, a spike in BDNF (a protein that supports neuron growth), and regrowth of the cortical synapses that depression has thinned out.

This all happens within hours. The subjective result is that the brain feels different quickly.

What "BDNF" and "neuroplasticity" actually mean

You'll see these words a lot in any discussion of ketamine. Translated:

BDNF (brain-derived neurotrophic factor) is a protein the brain releases that tells neurons to grow, strengthen connections, and form new ones. It's sometimes called "fertilizer for the brain" because it supports the same kind of growth and remodeling you'd want for learning, memory, and recovery from injury.

Neuroplasticity is the brain's capacity to change its own wiring. Learning a language is neuroplasticity. Recovering from a stroke is neuroplasticity. Getting out of a deep depressive pattern is also neuroplasticity — and chronic depression tends to suppress it.

Ketamine produces a burst of BDNF release and drives a window of heightened neuroplasticity that lasts roughly 24 to 72 hours after each session, tapering over the following week. That's the therapeutic window. It's why single sessions can produce changes that persist for days or weeks, and why a course of six or so sessions can produce changes that persist for months.

What the experience feels like

Patients commonly describe the session itself as a kind of floating, or watching their thoughts from a comfortable distance, or feeling the usual weight of self-concern ease up. The subjective effect is called dissociation, and it's a feature, not a side effect — it's part of how the therapeutic window opens. It typically lasts 45 to 90 minutes for sublingual ketamine (longer for IV) and fades gradually.

For a walkthrough of what a first session actually involves, see what to expect during your first at-home ketamine session.

The antidepressant effect is separate from the dissociation. Patients don't need a dramatic subjective experience to get the benefit. What they need is the neuroplasticity window the medication opens and some structured use of it — typically meaning real sleep, some journaling or reflection, ideally some therapeutic work, and attention to the small shifts in mood and thought that start to show up over the following days.

Why ketamine works when antidepressants haven't

About 30 to 40 percent of patients with depression don't respond adequately to SSRIs or SNRIs. This is called treatment-resistant depression, and it's not a failure of effort — it's usually a sign that the serotonin-modulating approach isn't the right match for that specific patient's neurobiology.

Ketamine works through a completely different pathway, so it can produce a response in patients who've cycled through multiple antidepressants without meaningful improvement. It's also rapid-acting, which matters for patients whose depression is severe enough that waiting six weeks for an SSRI to maybe work is not a reasonable plan.

What a treatment course actually looks like

Most at-home ketamine protocols run six sessions over six to eight weeks (the induction phase), followed by optional maintenance sessions spaced further apart if needed. During induction, patients typically notice sleep improvement first, then mood stabilization, then broader changes in energy, motivation, and outlook. The sequence and timing varies; so does the magnitude of response. Around 60-70% of treatment-resistant patients experience meaningful benefit.

Treatment is more effective when paired with deliberate psychological work — either formal ketamine-assisted psychotherapy or structured integration with a clinician the patient already trusts. The medication opens a window; what you do inside the window determines what gets built.

A note on format

Ketamine is delivered in several formats: IV infusion in clinics, esketamine nasal spray (Spravato) in certified settings, and oral sublingual formulations prescribed through physician-supervised at-home programs. The molecule is the same in each case. The differences come down to bioavailability, cost, and setting. For most patients who are medically appropriate for at-home treatment, the sublingual route is the most accessible and the most affordable by a significant margin.

Ready to start?

If you've been through several antidepressants and want to know whether ketamine therapy might be a reasonable next step, the five-minute eligibility check will give you a direct answer.

Discreet Ketamine provides at-home ketamine therapy supervised by Dr. Ben Soffer, a board-certified physician, to residents of Florida and New Jersey. Compounded racemic ketamine is prescribed off-label for depression, anxiety, PTSD, and chronic pain; it is not FDA-approved for these indications.